CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments

PartnershipPositive
AI Analysis

Summary

Mediar Therapeutics announced a collaboration and option agreement with Ono Pharmaceutical to develop treatments for fibro-inflammatory diseases.

Importance:5/10
Sentiment:
0.30
collaborationpartnershipfibro-inflammatory diseasesoption agreement
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 7, 2026 8:43 AM

Read Original